Big Investor Picks Up Large Stake In Allergan Inc. To Push For Valeant Pharmaceuticals International Merger

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - Hedge fund Paulson & Co has amassed a large stake in Allergan Inc (AGN.N) of more than 6 million shares and supports a deal between the Botox maker and Valeant Pharmaceuticals Inc (VRX.TO), people familiar with the matter said on Wednesday.

The position is expected to make the prominent U.S. hedge fund, led by John Paulson, one of the top 10 to 15 holders of Allergan, according to Thomson Reuters shareholder data as of March 31.

Help employers find you! Check out all the jobs and post your resume.

Back to news